Dr. Delfn earned a B.A. in Chemistry and Biological Sciences from Smith College (1994) and a Ph.D. in Medicinal Chemistry and Pharmacognosy (2007) from The Ohio State University.
Dr. Delfin's lab focuses on novel treatments for heart failure. Specifically, the lab investigates novel ways to support cardiac stem cell therapy to improve stem cell adhesion to the damaged extracellular matrix of failing hearts and promote differentiation into cardiomyocytes (heart muscle cells).